What Is the Serum Ferritin Level Required to Diagnose Iron Deficienc…

Robert Means

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

ASH 2024 Insights: COG AALL1731 - Blinatumomab Added to Chemo in New…

2024 ASH Annual Meeting Insights Hub

S. Gupta

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

WCLC 2024 Insights: Biology of CNS Metastases in NSCLC

Insights from 2024 WCLC

T. Burns

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe

WCLC 2024 Insights: Management of Brain Metastases in Oncogene-Drive…

Insights from 2024 WCLC

J. Chang

BRAF/MEK Targeted Therapy in Adult and Pediatric Glioma: Insights an…

Johns Hopkins

K. Schreck

Melanonychia Diagnosis, Evaluation, and Treatment

Scripps Health

F. Fish

Vorasidenib for Low Grade Gliomas

Stanford Medicine

T. Cao

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout